Evaluation of Anti-SARS-CoV-2 IgA in the Conjunctival Secretions of COVID-19 Patients

Figures & data

Table 1 Participant Data

Symptoms		Frequency	%
Dyspnea		11	25
Fever, Cough		7	15.9
GIT		3	6.8
Stability	Stable	11	25
	Ventilator	12	27.3
Ocular Symptoms	Yes	13	29.5
	No	31	70.5

Table 2 Results of IgA Detection and the Detection Titre

Severity	Reactive n (%)	Intermediate n (%)	Non-Reactive n (%)	Total n (%)	Titre Mean±SD
Mild	8(36.4)	1 (4.5)	13 (59.1)	22 (50)	13.85±21.40
Moderate	4 (40)	0 (0)	6 (60)	10 (22.7)	10.43±11.63
Severe	3 (25)	1 (8.3)	8 (66.7)	12 (27.3)	9.89±13.69
Total	15 (34.1)	2 (4.5)	27 (61.4)	44 (100)

Figure 1 Severity and IgA reactivity in the study group.

Table 3 Correlation Between Symptom Severity and IgA Titre

	Result	Titre
Ocular symptoms	r = 0.825 (p <0.001)	r= 0.50 (p = 0.001)
Severity	r = 0.070 (p = 0.65)	r=0.072 (p = 0.64)
r = 0.237 (p = 0.12)	r = 0.85 (p<0.001)

Table 4 Correlation Between IgA Reactivity and Age and Sex

	Age	Sex
Result	r = −0.15 (p = 0.92)	r = 0.054 (p = 0.73)